State reproductive rights advocates view a stockpile as one of a number of ways to protect access.
prescription drugs
Posted inLaw and Justice
The Case Without a Judge
The logical, absurd end point of Donald Trump’s government smash-and-grab
Posted inMoney, Politics, and Power
L.A. Times Owner Has Financial Motivations for Boosting RFK Jr.
Dr. Patrick Soon-Shiong’s biotech firm is preparing three applications needing approval from the Food and Drug Administration.
Posted inHealth and Social Policy
Trump’s Big Choice on Drug Prices
By following through on Biden’s Medicare price negotiation program, he can take credit for prescription reductions. But Big Pharma doesn’t want that to happen.
Posted inHealth and Social Policy
Congressional Drug-Pricing Reforms Upend Trump’s Strategy
He has typically allied with Big Pharma, pointing fingers at pharmacy benefit managers. But a bipartisan agreement could do away with that gambit.
Posted inHealth and Social Policy
The Empty Hope for RFK Jr.
Taking on Big Pharma and Big Ag isn’t a one-man job.
Posted inHealth and Social Policy
Family Providers Face Barriers to Adding Abortion Services
Malpractice insurance companies have piled on numerous restrictions and jacked up their rates. It’s become a new form of restricting access to abortion.
Posted inHealth and Social Policy
FTC Sues PBMs for Jacking Up Insulin Prices
The case against Caremark, Express Scripts, and Optum Rx is the first against this element of the pharmaceutical transaction chain.
Posted inLaw and Justice
Anti-Abortion Activists Pushed Amarillo to Help Save the Mifepristone Case
Far-right legal crusader Jonathan Mitchell thought that a local ordinance was key to create standing in the Supreme Court.
Posted inEconomic Policy
Polling Shows Voters Want to See Action on Corporate Power
The problem is the poll, shared exclusively with the Prospect, also shows that voters don’t believe the Biden-Harris administration has already taken action.